Can less radiation treat eye cancer just as well?
NCT ID NCT06432660
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tracks 42 people with ocular melanoma who received radiation therapy via eye plaque brachytherapy. Researchers want to see if using lower radiation doses can still keep the cancer from coming back while reducing harmful side effects. The goal is to find the safest effective dose.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- eye plaque brachytherapy (radiation therapy)
- What this could lead to
- If successful, this could show that lower radiation doses are just as effective at controlling ocular melanoma while causing fewer side effects.
- What could go wrong
- This is a small observational registry, not a randomized trial. It may not prove that lower doses are better, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OCULAR MELANOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Duke University Medical Center
Durham, North Carolina, 27710, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a vaccine keep melanoma from coming back? large trial tests immune boosters
- New drug shows promise in shrinking eye cancer before surgery
- New drug combo aims to tackle Hard-to-Treat cancers
- Scientists decode DNA of rare eye tumors to track Cancer's moves
- New combo therapy shows promise for brain metastases
- How does eye cancer treatment affect daily life? new study aims to find out